Thats why some pharmacies add it to tirzepatide formulations to make the treatment easier to tolerate for some patients
Recent studies have highlighted the utility of biomarkers, such as NGF and BDNF, in predicting the progression of neuropathy and response to therapy
Some pharmacies include the B6 at no additional charge as part of their standard tirzepatide formulation
In contrast, DFP treatment significantly decreased Fe 2+ levels in optic nerve tissue, downregulated TFR1 and Iba-1 expression, and inhibited iron deposition, ferroptosis, microglial activation, and astrocyte proliferation, thereby reducing myelin loss and optic nerve damage in MS mice (Rayatpour et al., 2022)
In May 2022, tirzepatide also gained FDA approval for the treatment of adults with type 2 diabetes and obesity
10.1016/j.intimp.2019.05.034